GlassScriptPhysician profile
Nhia Yang
NPI 1811307861
$366.74
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $95.89 · 2024: $38.91 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $85.86 | 2021-2024 | Freestyle Libre 3 |
| Viiv Healthcare Company | $31.81 | 2025 | Apretude |
| Lilly USA, LLC | $25.43 | 2025 | Zepbound, Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $25.00 | 2022 | |
| Ardelyx, INC. | $22.74 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $22.62 | 2025 | |
| Becton, Dickinson and Company | $18.15 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.78 | 2021 | |
| Novo Nordisk INC | $17.60 | 2021 | |
| Glaxosmithkline, LLC. | $17.36 | 2025 | Shingrix, Bexsero |
| Scilex Pharmaceuticals INC. | $14.89 | 2022 | |
| Qiagen, LLC | $14.87 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.74 | 2021 | |
| Amgen INC. | $13.42 | 2022 | |
| Abbvie INC. | $12.29 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vbi Vaccine (Delaware) INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nhia Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.